Both in Pharmaceuticals
Nuvectis Pharma vs Climb Bio
Over the past year NVCT returned +190.6% and CLYM returned +412.5%; their daily moves had a correlation of 0.26.
NVCT +190.6% CLYM +412.5%Growth of $1, one year, split-adjusted
| Metric | NVCT | CLYM |
|---|---|---|
| Price | $18.48 | $10.25 |
| Market cap | $603.3M | $588.7M |
| Today | −0.48% | −0.77% |
| 1 month | −10.8% | −7.4% |
| 6 months | +116.4% | +15.0% |
| Year to date | +144.8% | +156.3% |
| 1 year | +173.0% | +392.8% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $22.2M | $183.1M |
| Dividend yield | — | — |
| Volatility (60d) | 67.6% | 80.3% |
| Short % of float | 11.7% | 25.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).